List of works - Maria Koltowska-Häggström

Adaptation of the QoL-AGHDA scale for adults with growth hormone deficiency in four Slavic languages

scientific article

Application of the disease-specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in a general population: results from a French panel study

scientific article

Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations

scientific article published on 14 August 2009

Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (

scientific article

Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).

scientific article published in November 2004

Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction

scientific article published on 17 September 2013

Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease.

scientific article published on 20 January 2010

Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiency.

scientific article

Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.

scientific article

Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease

scientific article

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.

scientific article published in July 2006

Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy.

scientific article published on 24 November 2018

Diagnosis and management of acromegaly: the patient's perspective

scientific article published on 7 January 2016

Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?

scientific article published in July 2006

Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis

scientific article

Five-Year Postmarket Safety Experience With the Optimal Balance Technology Range of Hyaluronic Acid Fillers

scientific article published on 01 January 2020

GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database

scientific article published on 12 January 2015

GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients ⬇️

scientific article published on January 1, 2012

GH replacement in hypopituitarism improves lipid profile and quality of life independently of changes in obesity variables

scientific article

Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy

scientific article

Growth hormone (GH) replacement therapy in GH deficient adults: Predictors of one-year metabolic and clinical response

scientific article published on 12 January 2007

Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany.

scientific article published in June 2006

Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency.

scientific article published in November 2007

Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study

scientific article published on 10 November 2011

Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data

scientific article

Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.

scientific article published in October 2005

Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY.

scientific article published on 22 February 2012

Long-term treatment with pegvisomant as monotherapy in patients with acromegaly: experience from ACROSTUDY

scientific article

Magnetic resonance imaging of CNS in 15 043 children with GH deficiency in KIGS (Pfizer International Growth Database) ⬇️

scientific article published on January 17, 2013

Overall and cause-specific mortality in GH-deficient adults on GH replacement ⬇️

scientific article published on March 28, 2012

Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: data of the German KIMS cohort

scientific article published on August 23, 2011

Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis ⬇️

scientific article published on October 3, 2011

Quality of life in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention--radial versus femoral access (from the OCEAN RACE Trial).

scientific article

Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak

scientific article

Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).

scientific article

Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.

scientific article published in April 2005

Similar Clinical Features Among Patients with Severe Adult Growth Hormone Deficiency Diagnosed with Insulin Tolerance Test or Arginine or Glucagon Stimulation Tests ⬇️

scientific article published on May 1, 2012

Support Needs of Patients with Cushing's Disease and Cushing's Syndrome: Results of a Survey Conducted in Germany and the USA

article

The brazilian version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): Four-stage translation and validation

scientific article published on 01 December 2010

The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma

scientific article published in April 2005

The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden

scientific article published on 30 September 2013

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.

scientific article published on 8 August 2006

The metabolic consequences of thyroxine replacement in adult hypopituitary patients.

scientific article published in December 2012

The pituitary gland and age-dependent regulation of body composition.

scientific article

The presence of eye defects in patients with Turner syndrome is irrespective of their karyotype

scientific article

Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.

scientific article published in June 2004

Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study

scientific article published in March 2005

Which patients with acromegaly are treated with pegvisomant? An overview of methodology and baseline data in ACROSTUDY.

scientific article published on 14 August 2009

[Comment on the HSAN decision concerning Cesarean section and spinal analgesia: Pregnant women must be confident that adequate anesthesia is always provided]

scientific article published on 01 October 2009

List of works by Maria Koltowska-Häggström

Adaptation of the QoL-AGHDA scale for adults with growth hormone deficiency in four Slavic languages

Application of the disease-specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in a general population: results from a French panel study

Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations

Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (

Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).

Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction

Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease.

Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiency.

Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.

Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.

Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy.

Diagnosis and management of acromegaly: the patient's perspective

Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?

Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis

Five-Year Postmarket Safety Experience With the Optimal Balance Technology Range of Hyaluronic Acid Fillers

GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database

GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patients ⬇️

GH replacement in hypopituitarism improves lipid profile and quality of life independently of changes in obesity variables

Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy

Growth hormone (GH) replacement therapy in GH deficient adults: Predictors of one-year metabolic and clinical response

Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany.

Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency.

Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study

Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data

Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.

Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY.

Long-term treatment with pegvisomant as monotherapy in patients with acromegaly: experience from ACROSTUDY

Magnetic resonance imaging of CNS in 15 043 children with GH deficiency in KIGS (Pfizer International Growth Database) ⬇️

Overall and cause-specific mortality in GH-deficient adults on GH replacement ⬇️

Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: data of the German KIMS cohort

Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis ⬇️

Quality of life in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention--radial versus femoral access (from the OCEAN RACE Trial).

Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak

Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).

Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.

Similar Clinical Features Among Patients with Severe Adult Growth Hormone Deficiency Diagnosed with Insulin Tolerance Test or Arginine or Glucagon Stimulation Tests ⬇️

Support Needs of Patients with Cushing's Disease and Cushing's Syndrome: Results of a Survey Conducted in Germany and the USA

The brazilian version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): Four-stage translation and validation

The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma

The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.

The metabolic consequences of thyroxine replacement in adult hypopituitary patients.

The pituitary gland and age-dependent regulation of body composition.

The presence of eye defects in patients with Turner syndrome is irrespective of their karyotype

Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.

Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study

Which patients with acromegaly are treated with pegvisomant? An overview of methodology and baseline data in ACROSTUDY.

[Comment on the HSAN decision concerning Cesarean section and spinal analgesia: Pregnant women must be confident that adequate anesthesia is always provided]